The FDA said it would allow for a third primary series dose for certain immunocompromised children ages 5 through 11. (Pfizer) Share this article:FacebookTwitterLinkedInPinterestMorePrint
U.S. Congressman Greg Landsman takes oath of office in Cincinnati ceremony Jan 26, 2023 Cincinnati Herald
Richard A. Weiland was a prominent philanthropist, lobbyist and advisor Jan 26, 2023 Cincinnati Herald